April 16, 2015—The Department of Health and Human Services’ 340B orphan drug exclusion interpretive rule violates the 340B statute’s plain language and forces drugmakers either to obey “or face an enforcement action where HHS will be the government lawyer, the judge, and the jury,” drugmakers say in a new court filing.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)